Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07753447
PHASE4

Calorie Restricted Dietary Intervention in Type 2 Diabetes Patients With Obesity for Remission

Sponsor: Yeouido St. Mary's Hospital

View on ClinicalTrials.gov

Summary

This study aims to induce remission of type 2 diabetes through dietary intervention for weight reduction.

Key Details

Gender

All

Age Range

19 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

25

Start Date

2025-07-01

Completion Date

2026-02-28

Last Updated

2026-08-07

Healthy Volunteers

No

Interventions

DRUG

Contrave ER

Contrave is an extended-release combination of naltrexone and bupropion, approved for chronic weight management. It acts on the central nervous system to reduce appetite and control food cravings.

COMBINATION_PRODUCT

Low-calorie meal box

The meal boxes provided by CJ CheilJedang are nutritionally-balanced, low-calorie HMR products developed with reduced levels of sodium, sugar, and saturated fats.

Locations (1)

Yeouido Saint Mary's Hospital

Seoul, South Korea